- Home
- THFF vs STAA Comparison
THFF vs STAA Comparison
Compare THFF & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | THFF | STAA |
|---|---|---|
| Founded | 1984 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Ophthalmic Goods |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 796.4M | 867.9M |
| IPO Year | 1995 | 1995 |
Fundamental Metrics
Financial Performance| Metric | THFF | STAA |
|---|---|---|
| Price | $66.76 | $26.41 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $62.00 | $22.81 |
| AVG Volume (30 Days) | 71.4K | ★ 1.2M |
| Earning Date | 04-24-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.32% | N/A |
| EPS Growth | ★ 67.00 | N/A |
| EPS | ★ 6.68 | N/A |
| Revenue | N/A | ★ $239,442,000.00 |
| Revenue This Year | $17.86 | $28.87 |
| Revenue Next Year | $3.55 | $7.49 |
| P/E Ratio | $10.10 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $42.22 | $15.59 |
| 52 Week High | $69.21 | $30.81 |
Technical Indicators
Market Signals| Indicator | THFF | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 64.94 | 80.07 |
| Support Level | $64.80 | $23.79 |
| Resistance Level | $69.09 | $27.59 |
| Average True Range (ATR) | 1.49 | 1.14 |
| MACD | 0.63 | 0.80 |
| Stochastic Oscillator | 84.99 | 97.57 |
Price Performance
Historical ComparisonAbout THFF First Financial Corporation Indiana
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.